Clinical course features of newly diagnosed pulmonary tuberculosis treatment failure

Clinical characteristics of newly diagnosed tuberculosis patients with respiratory failure

Results Among 738 patients with tuberculosis who were admitted during January 2011 and December 2013, 60 were newly diagnosed. Of these, 35 (58.3%) patients had respiratory failure. When comparing those who had respiratory failure (RF) and those who did not (no RF), there was no significant difference in age (RF 47.3 ± 16.9 VS no RF 44.5 ± 15.8, P = 0.51), male sex (71.4% VS 68.0%, P = 0.76), B...

Clinical Efficacy of the Modified Treatment Scheme in Patients with Newly Diagnosed Pulmonary Tuberculosis

Effect of Poor Glycemic Control in Newly Diagnosed Patients with Smear-Positive Pulmonary Tuberculosis and Type-2 Diabetes Mellitus

Background: There is growing evidence that diabetes mellitus (DM) is an important risk factor for tuberculosis (TB). A significant number of DM patients have poor glycemic control. This study was carried out to find the impact of poor glycemic control on newly diagnosed smear-positive pulmonary tuberculosis patients with type-2 diabetes mellitus in a tertiary care hospital.Methods: In a hospita...

Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India

BACKGROUND & OBJECTIVES In the Revised National Tuberculosis Control Programme (RNTCP) in India prior to 2005, TB patients were offered standard DOTS regimens without knowledge of HIV status. Consequently such patients did not receive anti-retroviral therapy (ART) and the influence of concomitant HIV infection on the outcome of anti-tuberculosis treatment remained undetermined. This study was c...

Levamisole as an Adjuvant to Short-Course Therapy in Newly Diagnosed Pulmonary Tuberculosis Patients

BACKGROUND The estimated incidence and prevalence of tuberculosis in India are 2.1 and 2.6 million cases respectively. Immunotherapy may shorten tuberculosis treatments and improve the immunity of individuals as well. Hence we study the efficacy of levamisole (LVM) (immunomodulator) as an adjuvant to chemotherapy of pulmonary tuberculosis patients. MATERIALS AND METHODS A randomized, double-b...